Temaz and Electrocardiogram st-t change - a phase IV clinical study of FDA data

Summary:

Electrocardiogram st-t change is reported as a side effect among people who take Temaz (temazepam), especially for people who are male, 60+ old, also take Digoxin, and have Cardiac failure congestive.

The phase IV clinical study analyzes which people have Electrocardiogram st-t change when taking Temaz. It is created by eHealthMe based on reports of 40,916 people who have side effects when taking Temaz from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Electrocardiogram st-t change?

Electrocardiogram st-t change is found to be associated with 263 drugs and 410 conditions by eHealthMe. Check the latest studies of Electrocardiogram st-t change.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

40,916 people reported to have side effects when taking Temaz.
Among them, 13 people (0.03%) have Electrocardiogram st-t change.

Could Temaz cause Electrocardiogram st-t change?

Among these 13 people:

What is the gender of people who have Electrocardiogram st-t change when taking Temaz? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Electrocardiogram st-t change when taking Temaz? *

What are other drugs people take besides Temaz? *

Digoxin: 9 people, 69.23%
Lasix: 8 people, 61.54%
Aspirin: 7 people, 53.85%
Ativan: 7 people, 53.85%
Acetaminophen: 6 people, 46.15%
Hydrocodone Bitartrate And Acetaminophen: 6 people, 46.15%
Zocor: 6 people, 46.15%
Protonix: 6 people, 46.15%
Lexapro: 6 people, 46.15%
Pravachol: 5 people, 38.46%

What are other side effects people have besides Electrocardiogram st-t change? *

Weakness: 10 people, 76.92%
Nausea (feeling of having an urge to vomit): 8 people, 61.54%
Fatigue (feeling of tiredness): 8 people, 61.54%
Hypotension (abnormally low blood pressure): 7 people, 53.85%
Dizziness: 7 people, 53.85%
Mitral Valve Incompetence (inefficient heart valve): 7 people, 53.85%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 53.85%
Pleural Effusion (water on the lungs): 7 people, 53.85%
Cardiac Failure Congestive: 7 people, 53.85%
Dyspnea (difficult or laboured breathing): 6 people, 46.15%

What are the existing conditions these people have? *

Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 2 people, 15.38%
Cardiac Failure Congestive: 2 people, 15.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
Colon Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and have Electrocardiogram st-t change?

- Check whether Electrocardiogram st-t change is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temaz:

Temaz (42,293 reports)

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram st-t change:

Electrocardiogram st-t change (263 drugs)

Browse all the conditions that are associated with Electrocardiogram st-t change:

Electrocardiogram st-t change (410 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temaz) and Temaz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.